- Investing Ideas
- South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
SK Biopharmaceuticals
Market Cap: ₩7.7t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩97,800.00
7D
1.2%
1Y
8.9%
Oscotec
Market Cap: ₩1.6t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩42,250.00
7D
-10.5%
1Y
58.8%
DongKoo Bio & Pharma
Market Cap: ₩129.3b
Manufactures and sells pharmaceuticals in South Korea.
A006620
₩4,780.00
7D
0.1%
1Y
-15.8%
JW Shinyak
Market Cap: ₩92.1b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,648.00
7D
-2.0%
1Y
11.6%